MDT
Medtronic plc
Healthcare • CIK 0001613103
Loading...
Market Cap
$106.66B
P/E (TTM)
22.2x
Rev Growth (TTM)
+8.4%
Net Margin (TTM)
13.2%
FCF Yield (TTM)
5.1%
FCF Margin (TTM)
14.9%
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
10-K2026 FY2026-06-18source
8-KEarnings2026-06-03source
8-KMay 20262026-05-18source
8-KApr 20262026-04-24source
8-KMar 20262026-03-24source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
IR decks — not catalogued
Company-published, not SEC-audited
Earnings
Q4 FY2026
2 months ago
8-K releaseRevenue
N/A
—
Net Income
N/A
—
EPS
N/A
—
Earnings call — not catalogued
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$5.4B
Q4 '26
$2.1B-9%
Q3 '26
$2.3B+403%
FCF Margin
TTM14.9%
Q4 '2621.3%-17%
Sector: 0.0%Top 10%
OCF Margin20.2%
OCF/NI1.53x
CapEx Coverage3.8x
FCF Yield5.1%
FCF Growth (2Y)+6%
Cash Conversion Cycle
163 days
DSO: 64+DIO: 173−DPO: 74
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM4.4%
Div Yield3.4%
+Buyback (TTM)1.0%
Dividend & Payout Metrics
Dividend Yield (TTM)3.4%
FCF Payout Ratio67.0%
Free Cash Flow (TTM)$5.4B
Stock Repurchases (TTM)$1.0B
Capital Return / FCF86.1%
Est. Dividends Paid (TTM)$3.6B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
22.2x
Volatile
8Q: 23.7x+63%
Multiple expansion without fundamental improvement
Valuation Lenses
Earnings
22.2x
vs – sector
Cash Flow
25.6x
EV/FCF vs –
Growth-Adj
2.6xPEG
Expensive for growth
Quality-Adj
3.4P/E per %ROIC
ROIC: 6.6%
Shareholder Returns
Dividend
3.4%
Buyback
1.0%
Total Yield
4.4%
Market Cap$106.66B
EV$125.41B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
65.0%
Operating
17.8%
Top 25% in sector
Net
13.2%
Margins Unknown
Return on Invested CapitalTTM
6.6%
Stable
+0.0% YoY+0.4%
P25MedianP75
75th pctl (med: -0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.0%
8Q: 13.5%
Asset Turnover
0.40x
8Q: 0.38x
Leverage (1+D/E)
1.57x
D/E: 0.57x
DuPont: 8.7% ≈ 6.6% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
5.11x
8Q:5.10x
Flat
Invested Cap Turn
0.50x
8Q:0.48x
+6.2%
CapEx Intensity
2.6%
8Q:2.6%
CapEx/Depreciation
0.64x
FCF vs Net Margin Gap+1.7 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
D/E 0.57x
Net Debt / EBITDA
–Net Debt: $18.74B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.57x
Balance sheet risk & solvency analysis
Related Research
2 related posts